Vu M., Yu J., Awolude O.A., Chuang L. 2018. Cervical cancer worldwide. Curr. Probl. Cancer. 42 (5), 457—465.

Article  PubMed  Google Scholar 

Arbyn M., Weiderpass E., Bruni L., de Sanjosé S., Saraiya M., Ferlay J., Bray F. 2020. Estimates of incidence and mortality of cervical cancer in 2018: A worldwide analysis. Lancet Glob. Health. 8 (2), e191—e203.

Article  PubMed  Google Scholar 

Ryan M., Marlow L., Waller J. 2019. Socio-demographic correlates of cervical cancer risk factor knowledge among screening non-participants in Great Britain. Prev. Med. 125, 1–4.

Article  PubMed  PubMed Central  Google Scholar 

Small W., Jr., Bacon M.A., Bajaj A., Chuang L.T., Fisher B.J., Harkenrider M.M., Jhingran A., Kitchener H.C., Mileshkin L.R., Viswanathan A.N., Gaffney D.K. 2017. Cervical cancer: A global health crisis. Cancer. 123 (13), 2404—2412.

Article  PubMed  Google Scholar 

Pfaendler K.S., Tewari K.S. 2016. Changing paradigms in the systemic treatment of advanced cervical cancer. Am. J. Obstet. Gynecol. 214 (1), 22—30.

Article  PubMed  Google Scholar 

Zhu H., Luo H., Zhang W., Shen Z., Hu X., Zhu X. 2016. Molecular mechanisms of cisplatin resistance in cervical cancer. Drug. Des. Devel. Ther. 10, 1885—1895.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nieminen-Pihala V., Tarkkonen K., Laine J., Rummukainen P., Saastamoinen L., Nagano K., Baron R., Kiviranta R. 2021. Early B-cell Factor1 (Ebf1) promotes early osteoblast differentiation but suppresses osteoblast function. Bone. 146, 115884.

Article  CAS  PubMed  Google Scholar 

Armartmuntree N., Murata M., Techasen A., Yongvanit P., Loilome W., Namwat N., Pairojkul C., Sakonsinsiri C., Pinlaor S., Thanan R. 2018. Prolonged oxidative stress down-regulates Early B cell factor 1 with inhibition of its tumor suppressive function against cholangiocarcinoma genesis. Redox Biol. 14, 637—644.

Article  CAS  PubMed  Google Scholar 

Xing M., Ooi W.F., Tan J., Qamra A., Lee P.H., Li Z., Xu C., Padmanabhan N., Lim J.Q., Guo Y.A., Yao X., Amit M., Ng L.M., Sheng T., Wang J., Huang K.K., Anene-Nzelu C.G., Ho S.W.T., Ray M., Ma L., Fazzi G., Lim K.J., Wijaya G.C., Zhang S., Nandi T., Yan T., Chang M.M., Das K., Isa Z.F.A., Wu J., Poon P.S.Y., Lam Y.N., Lin J.S., Tay S.T., Lee M.H., Tan A.L.K., Ong X., White K., Rozen S.G., Beer M., Foo R.S.Y., Grabsch H.I., Skanderup A.J., Li S., Teh B.T., Tan P. 2020. Genomic and epigenomic EBF1 alterations modulate TERT expression in gastric cancer. J. Clin. Invest. 30 (6), 3005—3020.

Article  Google Scholar 

Zhu J., Wang H., Ma T., He Y., Shen M., Song W., Wang J.J., Shi J.P., Wu M.Y., Liu C., Wang W.J., Huang Y.Q. 2020. Identification of immune-related genes as prognostic factors in bladder cancer. Sci Rep. 10 (1), 19695.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shen Z., Chen Y., Li L., Liu L., Peng M., Chen X., Wu X., Sferra T.J., Wu M., Lin X., Cheng Y., Chu J., Shen A., Peng J. 2020. Transcription factor EBF1 over-expression suppresses tumor growth in vivo and in vitro via modulation of the PNO1/p53 pathway in colorectal cancer. Front. Oncol. 10, 1035.

Article  PubMed  PubMed Central  Google Scholar 

Ribera J., Morgades M., Zamora L., Montesinos P., Gómez-Seguí I., Pratcorona M., Sarrà J., Guàrdia R., Nomdedeu J., Tormo M., Martínez-Lopez J., Hernández-Rivas J.M., González-Campos J., Barba P., Escoda L., Genescà E., Solé F., Millá F., Feliu E., Ribera J.M.; Spanish PETHEMA Group and the Spanish Society of Hematology (2015) Prognostic significance of copy number alterations in adolescent and adult patients with precursor B acute lymphoblastic leukemia enrolled in PETHEMA protocols. Cancer. 121 (21), 3809—3817.

Article  CAS  PubMed  Google Scholar 

Del Cid J.S., Reed N.I., Molnar K., Liu S., Dang B., Jensen S.A., DeGrado W., Handford P.A., Sheppard D., Sundaram A.B. 2019. A disease-associated mutation in fibrillin-1 differentially regulates integrin-mediated cell adhesion. J. Biol. Chem. 294 (48), 18232—18243.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhai X., Xue Q., Liu Q., Guo Y., Chen Z. 2017. Colon cancer recurrence-associated genes revealed by WGCNA coexpression network analysis. Mol. Med. Rep. 16 (5), 6499—6505.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang W., Ota T., Shridhar V., Chien J., Wu B., Kuang R. 2013. Network-based survival analysis reveals subnetwork signatures for predicting outcomes of ovarian cancer treatment. PLoS Comput. Biol. 9 (3), e1002975.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Millstein J., Budden T., Goode E.L., Anglesio M.S., Talhouk A., Intermaggio M.P., Leong H.S., Chen S., Elatre W., Gilks B., Nazeran T., Volchek M., Bentley R.C., Wang C., Chiu D.S., Kommoss S., Leung S.C.Y., Senz J., Lum A., Chow V., Sudderuddin H., Mackenzie R., George J.; AOCS Group, Fereday S., Hendley J., Traficante N., Steed H., Koziak J.M., Köbel M., McNeish I.A., Goranova T., Ennis D., Macintyre G., Silva De Silva D., Ramón Y., Cajal T., García-Donas J., Hernando Polo S., Rodriguez G.C., Cushing-Haugen K.L., Harris H.R., Greene C.S., Zelaya R.A., Behrens S., Fortner R.T., Sinn P., Herpel E., Lester J., Lubiński J., Oszurek O., Tołoczko A., Cybulski C., Menkiszak J., Pearce C.L., Pike M.C., Tseng C., Alsop J., Rhenius V., Song H., Jimenez-Linan M., Piskorz A.M., Gentry-Maharaj A., Karpinskyj C., Widschwendter M., Singh N., Kennedy C.J., Sharma R., Harnett P.R., Gao B., Johnatty S.E., Sayer R., Boros J., Winham S.J, Keeney G.L., Kaufmann S.H., Larson M.C., Luk H., Hernandez B.Y., Thompson P.J., Wilkens L.R., Carney M.E., Trabert B., Lissowska J., Brinton L., Sherman M.E., Bodelon C., Hinsley S., Lewsley L.A., Glasspool R., Banerjee S.N., Stronach E.A., Haluska P., Ray-Coquard I., Mahner S., Winterhoff B., Slamon D., Levine D.A., Kelemen L.E., Benitez J., Chang-Claude J., Gronwald J., Wu A.H., Menon U., Goodman M.T., Schildkraut J.M., Wentzensen N., Brown R., Berchuck A., Chenevix-Trench G., deFazio A., Gayther S.A., García M.J., Henderson M.J., Rossing M.A., Beeghly-Fadiel A., Fasching P.A., Orsulic S., Karlan B.Y., Konecny G.E., Huntsman D.G., Bowtell D.D., Brenton J.D., Doherty J.A., Pharoah P.D.P., Ramus S.J. 2020. Prognostic gene expression signature for high-grade serous ovarian cancer. Ann. Oncol. 31 (9), 1240—1250.

Article  CAS  PubMed  Google Scholar 

Castro-Mondragon J.A., Riudavets-Puig R., Rauluseviciute I., Lemma R.B., Turchi L., Blanc-Mathieu R., Lucas J. Boddie P., Khan A., Manosalva Pérez N., Fornes O., Leung T.Y., Aguirre A., Hammal F., Schmelter D., Baranasic D., Ballester B., Sandelin A., Lenhard B., Vandepoele K., Wasserman W.W., Parcy F., Mathelier A. 2022. JASPAR 2022: The 9th release of the open-access database of transcription factor binding profiles. Nucleic Acids Res. 2022, D165—D173.

Saei Ghare Naz M., Kariman N., Ebadi A., Ozgoli G., Ghasemi V., Rashidi Fakari F. 2018. Educational interventions for cervical cancer screening behavior of women: A systematic review. Asian Pac. J. Cancer Prev. 19 (4), 875—884.

PubMed  Google Scholar 

Webb K., Prakash V., Kirresh O., Stewart A. 2018. A case of aortitis during cisplatin-based chemotherapy for cervical cancer. BJR Case Rep. 5 (1), 20180054.

PubMed  PubMed Central  Google Scholar 

Li R., Song Y., Chen X., Chu M., Wang Z.-W., Zhu X. 2021. METTL3 increases cisplatin chemosensitivity of cervical cancer cells via downregulation of the activity of RAGE. Mol. Ther. Oncolytics. 22, 245—255.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bullerwell C.E., Robichaud P.P., Deprez P.M.L., Joy A.P., Wajnberg G., D’Souza D., Chacko S., Fournier S., Crapoulet N., Barnett D.A., Lewis S.M., Ouellette R.J. 2021. EBF1 drives hallmark B cell gene expression by enabling the interaction of PAX5 with the MLL H3K4 methyltransferase complex. Sci. Rep. 11 (1), 1537.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Harder L., Eschenburg G., Zech A., Kriebitzsch N., Otto B., Streichert T., Behlich A.S., Dierck K., Klingler B., Hansen A., Stanulla M., Zimmermann M., Kremmer E., Stocking C., Horstmann M.A. 2013. Aberrant ZNF423 impedes B cell differentiation and is linked to adverse outcome of ETV6-RUNX1 negative B precursor acute lymphoblastic leukemia. J. Exp. Med. 210 (11), 2289—2304.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xu X., Huang A., Cui X., Han K., Hou X., Wang Q., Cui L., Yang Y. 2019. Ubiquitin specific peptidase 5 regulates colorectal cancer cell growth by stabilizing Tu translation elongation factor. Theranostics. 9 (14), 4208—4220.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mo X., Su Z., Yang B., Zeng Z., Lei S., Qiao H. 2020. Identification of key genes involved in the development and progression of early-onset colorectal cancer by co-expression network analysis. Oncol. Lett. 19 (1), 177—186.

CAS  PubMed  Google Scholar 

Wang Z., Tu L., Chen M., Tong S. 2021. Identification of a tumor microenvironment-related seven-gene signature for predicting prognosis in bladder cancer. BMC Cancer. 21 (1), 692.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Che X., Jian F., Wang Y., Zhang J., Shen J., Cheng Q., Wang X., Jia N., Feng W. 2020. FBXO2 Promotes proliferation of endometrial cancer by ubiquitin-mediated degradation of FBN1 in the regulation of the cell cycle and the autophagy pathway. Front. Cell Dev. Biol. 8, 843.

Article  PubMed  PubMed Central  Google Scholar 

Yang D., Zhao D., Chen X. 2017. MiR-133b inhibits proliferation and invasion of gastric cancer cells by up-regulating FBN1 expression. Cancer Biomark. 19 (4), 425—436.

Article  CAS  PubMed  Google Scholar 

Wang Z., Liu Y., Lu L., Yang L., Yin S., Wang Y., Qi Z., Meng J., Zang R., Yang G. 2015. Fibrillin-1, induced by Aurora-A but inhibited by BRCA2, promotes ovarian cancer metastasis. Oncotarget. 6 (9), 6670—6683.

Article  PubMed  PubMed Central  Google Scholar 

Wang Z., Chen W., Zuo L., Xu M., Wu Y., Huang J., Zhang X., Li Y., Wang J., Chen J., Wang H., Sun H. 2022. The Fibrillin-1/VEGFR2/STAT2 signaling axis promotes chemoresistance via modulating glycolysis and angiogenesis in ovarian cancer organoids and cells. Cancer Commun. (London). 42 (3), 245—265.

Article  CAS  Google Scholar